Middle East and Africa Pelvic Floor Electric Stimulator Market - Industry Trends and Forecast to 2028

TABLE OF CONTENT

TABLE OF CONTENTS 1 INTRODUCTION 18 1.1 OBJECTIVES OF THE STUDY 18 1.2 MARKET DEFINITION 18 1.3 OVERVIEW OF MIDDLE EAST & AFRICA PELVIC FLOOR ELECTRIC STIMULATOR MARKET 18 1.4 LIMITATIONS 20 1.5 MARKETS COVERED 20 2 MARKET SEGMENTATION 22 2.1 MARKETS COVERED 22 2.2 GEOGRAPHICAL SCOPE 23 2.3 YEARS CONSIDERED FOR THE STUDY 24 2.4 CURRENCY AND PRICING 24 2.5 DBMR TRIPOD DATA VALIDATION MODEL 25 2.6 MULTIVARIATE MODELLING 28 2.7 PRODUCT TYPE LIFELINE CURVE 28 2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 29 2.9 DBMR MARKET POSITION GRID 30 2.10 MARKET APPLICATION COVERAGE GRID 31 2.11 VENDOR SHARE ANALYSIS 32 2.12 SECONDARY SOURCES 33 2.13 ASSUMPTIONS 33 3 EXECUTIVE SUMMARY 34 4 PREMIUM INSIGHTS 37 5 MIDDLE EAST & AFRICA PELVIC FLOOR ELECTRIC STIMULATOR MARKET: REGULATIONS 38 5.1 U.S 38 5.2 EUROPE 39 5.3 CHINA 39 5.4 AUSTRALIA 40 6 MARKET OVERVIEW 41 6.1 DRIVERS 43 6.1.1 RISING GERIATRIC POPULATION 43 6.1.2 INCREASING PREVALENCE OF CHRONIC DISEASES 46 6.1.3 INTRODUCTION OF ADVANCE TECHNOLOGY BASED PELVIC FLOOR ELECTRIC STIMULATOR 48 6.1.4 RISING PER CAPITA INCOME 48 6.2 RESTRAINTS 49 6.2.1 HIGH COST OF PELVIC FLOOR ELECTRIC STIMULATOR 49 6.2.2 LACK OF AWARENESS 50 6.3 OPPORTUNITIES 50 6.3.1 INCREASING HEALTHCARE EXPENDITURE ACROSS THE WORLD 50 6.3.2 ADVANCEMENT IN HEALTHCARE INFRASTRUCTURE 52 6.3.3 STRATEGIC INITIATIVES BY KEY MARKET PLAYERS 53 6.4 CHALLENGES 53 6.4.1 LACK OF ACCESSIBILITY 53 6.4.2 STRINGENT REGULATION POLICY 54 7 IMPACT OF COVID-19 ON THE MIDDLE EAST & AFRICA PELVIC FLOOR ELECTRIC STIMULATOR MARKET 56 7.1 IMPACT ON PRICE 56 7.2 IMPACT ON DEMAND 56 7.3 IMPACT ON SUPPLY CHAIN 56 7.4 STRATEGIC DECISIONS FOR MANUFACTURERS 57 7.5 CONCLUSION 57 8 MIDDLE EAST & AFRICA PELVIC FLOOR ELECTRIC STIMULATOR MARKET, BY PRODUCT TYPE 58 8.1 OVERVIEW 59 8.2 MOBILE 62 8.2.1 HAND-HELD 62 8.2.2 TRANSPORTABLE 63 8.3 FIXED 63 8.3.1 TABLE-TOP 64 8.3.2 TROLLEY-FIXED 64 8.4 WEARABLE 64 9 MIDDLE EAST & AFRICA PELVIC FLOOR ELECTRIC STIMULATOR MARKET, BY DEVICE TYPE 65 9.1 OVERVIEW 66 9.2 NON-IMPLANTABLE ELECTRICAL STIMULATOR DEVICE 69 9.3 IMPLANTABLE ELECTRICAL STIMULATOR DEVICE 69 10 MIDDLE EAST & AFRICA PELVIC FLOOR ELECTRIC STIMULATOR MARKET, BY NUMBER OF CHANNELS 71 10.1 OVERVIEW 72 10.2 1 CHANNEL 75 10.3 2 CHANNEL 76 11 MIDDLE EAST & AFRICA PELVIC FLOOR ELECTRIC STIMULATOR MARKET, BY THERAPY 77 11.1 OVERVIEW 78 11.2 PHYSICAL THERAPY 81 11.3 OCCUPATIONAL THERAPY 82 12 MIDDLE EAST & AFRICA PELVIC FLOOR ELECTRIC STIMULATOR MARKET, BY TREATMENT 83 12.1 OVERVIEW 84 12.2 PELVIC FLOOR MUSCLE TRAINING (PFMT) 87 12.3 INTRAVAGINAL NEUROMUSCULAR ELECTRICAL STIMULATION (NMES) 88 12.4 TRANSCUTANEOUS TIBIAL NERVE STIMULATION (TTNS) 89 13 MIDDLE EAST & AFRICA PELVIC FLOOR ELECTRIC STIMULATOR MARKET, BY APPLICATION 90 13.1 OVERVIEW 91 13.2 URINARY INCONTINENCE 94 13.3 SEXUAL DYSFUNCTION 95 13.4 NEURODEGENERATIVE DISEASES 96 13.5 OTHERS 97 14 MIDDLE EAST & AFRICA PELVIC FLOOR ELECTRIC STIMULATOR MARKET, BY END USER 98 14.1 OVERVIEW 99 14.2 HOSPITALS 102 14.2.1 ACUTE CARE HOSPITALS 103 14.2.2 LONG-TERM CARE HOSPITALS 103 14.2.3 NURSING FACILITIES 103 14.2.4 REHABILITATION CENTERS 103 14.3 CLINICS 103 14.4 HOME-CARE SETTINGS 104 15 MIDDLE EAST & AFRICA PELVIC FLOOR ELECTRIC STIMULATOR MARKET, BY DISTRIBUTION CHANNEL 105 15.1 OVERVIEW 106 15.2 DIRECT TENDERS 109 15.3 THIRD PARTY DISTRIBUTION 110 15.4 OTHERS 111 16 MIDDLE EAST & AFRICA PELVIC FLOOR ELECTRIC STIMULATOR MARKET, BY GEOGRAPHY 112 16.1 OVERVIEW 113 16.2 MIDDLE EAST & AFRICA 119 16.2.1 SOUTH AFRICA 126 16.2.2 SAUDI ARABIA 129 16.2.3 UAE 132 16.2.4 EGYPT 135 16.2.5 ISRAEL 138 16.2.6 REST OF MIDDLE EAST & AFRICA 141 17 MIDDLE EAST & AFRICA PELVIC FLOOR ELECTRIC STIMULATOR MARKET: COMPANY LANDSCAPE 142 17.1 COMPANY SHARE ANALYSIS: MIDDLE EAST & AFRICA 142 18 SWOT 143 19 COMPANY PROFILES 144 19.1 LABORIE, INC. 144 19.1.1 COMPANY SNAPSHOT 144 19.1.2 COMPANY SHARE ANALYSIS 144 19.1.3 PRODUCT PORTFOLIO 145 19.1.4 RECENT DEVELOPMENTS 145 19.2 UTAH MEDICAL PRODUCTS, INC. 146 19.2.1 COMPANY SNAPSHOT 146 19.2.2 REVENUE ANALYSIS 146 19.2.3 COMPANY SHARE ANALYSIS 147 19.2.4 PRODUCT PORTFOLIO 147 19.2.5 RECENT DEVELOPMENT 147 19.3 INCONTROL MEDICAL 148 19.3.1 COMPANY SNAPSHOT 148 19.3.2 COMPANY SHARE ANALYSIS 148 19.3.3 PRODUCT PORTFOLIO 149 19.3.4 RECENT DEVELOPMENTS 149 19.4 SHENZHEN XFT MEDICAL LIMITED 150 19.4.1 COMPANY SNAPSHOT 150 19.4.2 COMPANY SHARE ANALYSIS 150 19.4.3 PRODUCT PORTFOLIO 151 19.4.4 RECENT DEVELOPMENT 151 19.5 TIC MEDIZINTECHNIK GMBH & CO. KG 152 19.5.1 COMPANY SNAPSHOT 152 19.5.2 PRODUCT PORTFOLIO 152 19.5.3 RECENT DEVELOPMENT 152 19.6 ATLANTIC THERAPEUTICS 153 19.6.1 COMPANY SNAPSHOT 153 19.6.2 PRODUCT PORTFOLIO 153 19.6.3 RECENT DEVELOPMENT 153 19.7 CLEO 154 19.7.1 COMPANY SNAPSHOT 154 19.7.2 PRODUCT PORTFOLIO 154 19.7.3 RECENT DEVELOPMENT 154 19.8 EVERYWAY MEDICAL INSTRUMENTS CO., LTD 155 19.8.1 COMPANY SNAPSHOT 155 19.8.2 PRODUCT PORTFOLIO 155 19.8.3 RECENT DEVELOPMENT 155 19.9 GYMNAUNIPHY 156 19.9.1 COMPANY SNAPSHOT 156 19.9.2 PRODUCT PORTFOLIO 156 19.9.3 RECENT DEVELOPMENTS 156 19.10 NOVUQARE 157 19.10.1 COMPANY SNAPSHOT 157 19.10.2 PRODUCT PORTFOLIO 157 19.10.3 RECENT DEVELOPMENTS 157 19.11 RELEVIUM LABS INC. 159 19.11.1 COMPANY SNAPSHOT 159 19.11.2 PRODUCT PORTFOLIO 159 19.11.3 RECENT DEVELOPMENT 159 19.12 SUGAR INTERNATIONAL 160 19.12.1 COMPANY SNAPSHOT 160 19.12.2 PRODUCT PORTFOLIO 160 19.12.3 RECENT DEVELOPMENT 160 19.13 SUNMEDIX CO, LTD. 161 19.13.1 COMPANY SNAPSHOT 161 19.13.2 PRODUCT PORTFOLIO 161 19.13.3 RECENT DEVELOPMENT 161 19.14 THE PROMETHEUS GROUP 162 19.14.1 COMPANY SNAPSHOT 162 19.14.2 PRODUCT PORTFOLIO 162 19.14.3 RECENT DEVELOPMENT 162 19.15 VERITY MEDICAL LTD 163 19.15.1 COMPANY SNAPSHOT 163 19.15.2 PRODUCT PORTFOLIO 163 19.15.3 RECENT DEVELOPMENT 163 19.16 V2U HEALTHCARE 164 19.16.1 COMPANY SNAPSHOT 164 19.16.2 PRODUCT PORTFOLIO 164 19.16.3 RECENT DEVELOPMENTS 164 20 QUESTIONNAIRE 165 21 RELATED REPORTS 168